
    
      The investigators are undertaking a parallel group, multicenter, randomized controlled trial
      of 100 adults with ITP in China. Patients were randomized to tacrolimuis plus high-dose
      dexamethasone and high-dose dexamethasone monotherapy group. Platelet count, bleeding and
      other symptoms were evaluated before and after treatment. Adverse events are also recorded
      throughout the study.
    
  